Drake MT. Osteoporosis and cancer. Curr Osteoporos Rep. 2013;11(3):163–70.

Article  PubMed  PubMed Central  Google Scholar 

Bernstein ZS, Kim EB, Raje N. Bone Disease in Multiple Myeloma: Biologic and Clinical Implications. Cells. 2022;11(15).

Nuti R, Brandi ML, Checchia G, Di Munno O, Dominguez L, Falaschi P, Fiore CE, Iolascon G, Maggi S, Michieli R, et al. Guidelines for the management of osteoporosis and fragility fractures. Intern Emerg Med. 2019;14(1):85–102.

Article  PubMed  Google Scholar 

Oefelein MG, Ricchiuti V, Conrad W, Resnick MI. Skeletal fractures negatively correlate with overall survival in men with prostate cancer. J Urol. 2002;168(3):1005–7.

Article  PubMed  Google Scholar 

Guise TA. Bone loss and fracture risk associated with cancer therapy. Oncologist. 2006;11(10):1121–31.

Article  CAS  PubMed  Google Scholar 

Griffeth LK. Use of PET/CT scanning in cancer patients: technical and practical considerations. Proc (Bayl Univ Med Cent). 2005;18(4):321–30.

PubMed  Google Scholar 

Walker-Bone K. Recognizing and treating secondary osteoporosis. Nat Rev Rheumatol. 2012;8(8):480–92.

Article  CAS  PubMed  Google Scholar 

Hofbauer LC, Hamann C, Ebeling PR. Approach to the patient with secondary osteoporosis. Eur J Endocrinol. 2010;162(6):1009–20.

Article  CAS  PubMed  Google Scholar 

Khosla S, Oursler MJ, Monroe DG. Estrogen and the skeleton. Trends Endocrinol Metab. 2012;23(11):576–81.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Qadir A, Liang S, Wu Z, Chen Z, Hu L, Qian A. Senile osteoporosis: the involvement of differentiation and senescence of bone marrow stromal cells. Int J Mol Sci, 2020. 21(1).

Hawkins F, Garla V, Allo G, Males D, Mola L, Corpas E. In: Corpas E, editor. Chap. 5 - senile and postmenopausal osteoporosis: pathophysiology, diagnosis, and treatment, in Endocrinology of Aging. Editor: Elsevier; 2021. pp. 131–69.

Google Scholar 

Colangelo L, Biamonte F, Pepe J, Cipriani C, Minisola S. Understanding and managing secondary osteoporosis. Expert Rev Endocrinol Metabolism. 2019;14(2):111–22.

Article  CAS  Google Scholar 

Briot K, Roux C. Glucocorticoid-induced osteoporosis. RMD Open. 2015;1(1):e000014.

Article  PubMed  PubMed Central  Google Scholar 

Peng CH, Lin WY, Yeh KT, Chen IH, Wu WT, Lin MD. The molecular etiology and treatment of glucocorticoid-induced osteoporosis. Tzu Chi Med J. 2021;33(3):212–23.

Article  PubMed  PubMed Central  Google Scholar 

Chotiyarnwong P, McCloskey EV. Pathogenesis of glucocorticoid-induced osteoporosis and options for treatment. Nat Rev Endocrinol. 2020;16(8):437–47.

Article  PubMed  Google Scholar 

S AMEB, Salawu A, Brown JE. Bone Health Men Prostate Cancer: Rev Article Curr Osteoporos Rep. 2019;17(6):527–37.

Google Scholar 

Kim TJ, Koo KC. Pathophysiology of bone loss in patients with prostate Cancer receiving androgen-deprivation therapy and lifestyle modifications for the management of Bone Health: a Comprehensive Review. Cancers (Basel), 2020. 12(6).

Yao Z, Murali B, Ren Q, Luo X, Faget DV, Cole T, Ricci B, Thotala D, Monahan J, van Deursen JM, et al. Therapy-Induced Senescence Drives Bone Loss Cancer Res. 2020;80(5):1171–82.

CAS  PubMed  Google Scholar 

Farr JN, Xu M, Weivoda MM, Monroe DG, Fraser DG, Onken JL, Negley BA, Sfeir JG, Ogrodnik MB, Hachfeld CM, et al. Targeting cellular senescence prevents age-related bone loss in mice. Nat Med. 2017;23(9):1072–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bouvard B, Royer M, Chappard D, Audran M, Hoppe E, Legrand E. Monoclonal gammopathy of undetermined significance, multiple myeloma, and osteoporosis. Joint Bone Spine. 2010;77(2):120–4.

Article  CAS  PubMed  Google Scholar 

Salim H, Ariawati K, Suryawan WB, Arimbawa M. Osteoporosis resulting from acute lymphoblastic leukemia in a 7-year-old boy: a case report. J Med Case Rep. 2014;8:168.

Article  PubMed  PubMed Central  Google Scholar 

Haddy TB, Mosher RB, Reaman GH. Osteoporosis in survivors of acute lymphoblastic leukemia. Oncologist. 2001;6(3):278–85.

Article  CAS  PubMed  Google Scholar 

Morgan SL, Prater GL. Quality in dual-energy X-ray absorptiometry scans. Bone. 2017;104:13–28.

Article  CAS  PubMed  Google Scholar 

Sozen T, Ozisik L, Basaran NC. An overview and management of osteoporosis. Eur J Rheumatol. 2017;4(1):46–56.

Article  PubMed  Google Scholar 

Pickhardt PJ, Pooler BD, Lauder T, del Rio AM, Bruce RJ, Binkley N. Opportunistic screening for osteoporosis using abdominal computed tomography scans obtained for other indications. Ann Intern Med. 2013;158(8):588–95.

Article  PubMed  PubMed Central  Google Scholar 

Park SH, Jeong YM, Lee HY, Kim EY, Kim JH, Park HK, Ahn HK. Opportunistic use of chest CT for screening osteoporosis and predicting the risk of incidental fracture in breast cancer patients: a retrospective longitudinal study. PLoS ONE. 2020;15(10):e0240084.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pickhardt PJ, Nguyen T, Perez AA, Graffy PM, Jang S, Summers RM, Garrett JW. Improved CT-based osteoporosis Assessment with a fully automated Deep Learning Tool. Radiol Artif Intell. 2022;4(5):e220042.

Article  PubMed  PubMed Central  Google Scholar 

O’Gorman CA, Milne S, Lambe G, Sobota A, Beddy P, Gleeson N. Accuracy of opportunistic bone Mineral Density Assessment on staging computed tomography for gynaecological cancers. Med (Kaunas), 2021. 57(12).

Cohen A, Foldes AJ, Hiller N, Simanovsky N, Szalat A. Opportunistic screening for osteoporosis and osteopenia by routine computed tomography scan: a heterogeneous, multiethnic, middle-eastern population validation study. Eur J Radiol. 2021;136:109568.

Article  PubMed  Google Scholar 

Lee S, Chung CK, Oh SH, Park SB. Correlation between bone Mineral Density measured by dual-energy X-Ray absorptiometry and hounsfield units measured by diagnostic CT in lumbar spine. J Korean Neurosurg Soc. 2013;54(5):384–9.

Article  PubMed  PubMed Central  Google Scholar 

Zou D, Li W, Deng C, Du G, Xu N. The use of CT Hounsfield unit values to identify the undiagnosed spinal osteoporosis in patients with lumbar degenerative diseases. Eur Spine J. 2019;28(8):1758–66.

Article  PubMed  Google Scholar 

Schreiber JJ, Anderson PA, Rosas HG, Buchholz AL, Au AG. Hounsfield units for assessing bone mineral density and strength: a tool for osteoporosis management. J Bone Joint Surg Am. 2011;93(11):1057–63.

Article  PubMed  Google Scholar 

Batawil N, Sabiq S. Hounsfield unit for the diagnosis of bone mineral density disease: a proof of concept study. Radiography. 2016;22(2):e93–8.

Article  Google Scholar 

Sadaghiani MS, Rowe SP, Sheikhbahaei S. Applications of artificial intelligence in oncologic (18)F-FDG PET/CT imaging: a systematic review. Ann Transl Med. 2021;9(9):823.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rohren EM, Turkington TG, Coleman RE. Clinical applications of PET in oncology. Radiology. 2004;231(2):305–32.

Article  PubMed  Google Scholar 

Cohen B, Hiller N, Szalat A, Vainstein V. Opportunistic evaluation of bone Mineral Density by Pet-Ct in Hodgkin Lymphoma Patients. Endocr Pract. 2019;25(9):869–76.

Article  PubMed  Google Scholar 

Ofshenko N, Bercovich E, Mashiach T, Weiler-Sagie M, Militianu D, Dann EJ. Reduction of the vertebral bone Mineral density in patients with Hodgkin Lymphoma Correlates with their age and the treatment regimen they received. Volume 14. Cancers (Basel); 2022. 3.

Kay FU, Ho V, Dosunmu EB, Chhabra A, Brown K, Duan X, Oz OK. Quantitative CT detects undiagnosed low bone Mineral density in oncologic patients imaged with 18F-FDG PET/CT. Clin Nucl Med. 2021;46(1):8–15.

Article